Login / Signup

Evaluating Access to Prescription Medications in the Atopic Dermatitis Patient Population in the USA.

Allison R LoiselleRaj ChovatiyaIsabelle J ThibauJessica K JohnsonMichele GuadalupeWendy Smith Begolka
Published in: Dermatology and therapy (2024)
Patients with AD frequently experience insurance-related barriers to obtaining recommended therapies, and many do not know how to respond when these barriers arise. Strategies to improve timely therapeutic access are needed.
Keyphrases
  • atopic dermatitis
  • case report
  • health insurance
  • healthcare
  • affordable care act
  • long term care